Joshua Briscoe

Orlando Health

Papers

1

Total Citations

13

H-Index

1

About

Joshua Briscoe is a rising figure in urologic oncology, whose work sits at the intersection of artificial intelligence and surgical outcomes for prostate cancer. His primary research focuses on leveraging machine learning to predict functional recovery after robotic-assisted radical prostatectomy, a critical concern for patients facing treatment decisions. His most-cited paper, published in 2024, introduces an AI-based model that forecasts urinary continence and erectile function recovery with notable accuracy, drawing on data from a major prostate cancer referral center. This contribution has already garnered 13 citations, signaling its immediate relevance to both clinicians and researchers seeking to personalize postoperative care. Briscoe’s work stands out for its practical aim: translating complex predictive analytics into tools that can guide patient counseling and set realistic expectations. By bridging the gap between advanced computational methods and real-world clinical challenges, he is helping to shape a future where surgical outcomes are not just treated, but anticipated. His research is particularly valuable for students and practitioners interested in the growing role of AI in precision medicine and patient-centered oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Development and Assessment of an AI-based Machine Learning Model for Predicting Urinary Continence and Erectile Function Recovery after Robotic-Assisted Radical Prostatectomy: Insights from a Prostate Cancer Referral Center
13 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Orlando Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago